Keywords: abpi/bia, task, force, wake, tgn1412, tragic, adverse

ABPI/BIA task force in wake of TGN1412

Article | 29 May 2006

Print This

In the wake of the tragic adverse reactions to German firm TeGenero's monoclonal antibody drug TGN1412, seen in a trial ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in